Membrane Interactions and Toxicity by Misfolded Protein Oligomers

Area of Science:

• Biochemistry
• Neuroscience
• Cell Biology

Background:

• Protein misfolding and aggregation into amyloid fibrils are hallmarks of neurodegenerative diseases like Alzheimer's and Parkinson's.
• Small prefibrillar oligomers are increasingly recognized as the most toxic species in protein aggregation.
• These toxic oligomers are also implicated in non-neuropathic conditions such as type II diabetes and systemic amyloidoses.

Purpose of the Study:

• To review recent advances in characterizing the cellular and molecular interactions of toxic misfolded protein oligomers.
• To elucidate the mechanisms by which these oligomers cause cellular toxicity, focusing on their interactions with biological membranes.

Main Methods:

• Review of current literature on protein misfolding diseases and oligomer interactions.
• Analysis of proposed models for oligomer-induced cellular toxicity.
• Discussion of challenges in characterizing transient and heterogeneous protein aggregate interactions.

Main Results:

• Toxic protein oligomers interact fundamentally with biological membranes.
• Two primary mechanisms of cellular toxicity are proposed: membrane disruption leading to cellular dysfunction and direct alteration of membrane protein function.
• Membrane disruption can result in calcium imbalance, mitochondrial dysfunction, and increased reactive oxygen species.

Conclusions:

• Understanding the interactions between toxic protein oligomers and cell membranes is crucial for comprehending protein misfolding diseases.
• Characterizing transient interactions with heterogeneous aggregates remains a significant challenge.
• Identifying therapeutic strategies to mitigate oligomer-induced cellular toxicity is a critical goal for treating these diseases.